Quantitation of paclitaxel in micro-sample rat plasma by a sensitive reversed-phase HPLC assay

A sensitive high-performance liquid chromatographic (HPLC) method was developed for the determination of paclitaxel in micro-samples of rat plasma in order to study the mechanism of enhanced systemic exposure of paclitaxel co-administered with P-glycoprotein inhibitors. The assay involved solid-phas...

Full description

Saved in:
Bibliographic Details
Published inJournal of pharmaceutical and biomedical analysis Vol. 31; no. 2; pp. 283 - 289
Main Authors Wang, L.Z, Ho, P.C, Lee, H.S, Vaddi, H.K, Chan, Y.W, Yung, Chan Sui
Format Journal Article
LanguageEnglish
Published Amsterdam Elsevier B.V 26.02.2003
Elsevier Science
Subjects
Online AccessGet full text

Cover

Loading…
Abstract A sensitive high-performance liquid chromatographic (HPLC) method was developed for the determination of paclitaxel in micro-samples of rat plasma in order to study the mechanism of enhanced systemic exposure of paclitaxel co-administered with P-glycoprotein inhibitors. The assay involved solid-phase extraction procedures using 2′-methylpaclitaxel as the internal standard. Chromatographic separations were achieved using a ZORBAX ODS C18 column and mobile phase consisting of acetonitrile, methanol and ammonium acetate buffer (10 mM, pH 5.0) (48.5:16.5:35) pumped at 0.8 ml/min. The effluents were measured for UV absorption at 227 nm, with retention times of 8.5 and 11.0 min for paclitaxel and 2′-methylpaclitaxel, respectively. The chromatographic separation was excellent, with no endogenous interference. The standard curves showed a good linearity ( r=0.9994) over the concentration ranges of 10–1000 ng/ml. At 1000 ng/ml, the absolute recoveries of paclitaxel and 2′-methylpaclitaxel are 89 and 90%, respectively. The intra- and inter-day variabilities of paclitaxel were both less than 15%. This validated method for the assay of paclitaxel in micro-sample rat plasma made it feasible to study the pharmacokinetics of the drug in a single rat.
AbstractList A sensitive high-performance liquid chromatographic (HPLC) method was developed for the determination of paclitaxel in micro-samples of rat plasma in order to study the mechanism of enhanced systemic exposure of paclitaxel co-administered with P-glycoprotein inhibitors. The assay involved solid-phase extraction procedures using 2'-methylpaclitaxel as the internal standard. Chromatographic separations were achieved using a ZORBAX ODS C18 column and mobile phase consisting of acetonitrile, methanol and ammonium acetate buffer (10 mM, pH 5.0) (48.5:16.5:35) pumped at 0.8 ml/min. The effluents were measured for UV absorption at 227 nm, with retention times of 8.5 and 11.0 min for paclitaxel and 2'-methylpaclitaxel, respectively. The chromatographic separation was excellent, with no endogenous interference. The standard curves showed a good linearity (r=0.9994) over the concentration ranges of 10-1,000 ng/ml. At 1,000 ng/ml, the absolute recoveries of paclitaxel and 2'-methylpaclitaxel are 89 and 90%, respectively. The intra- and inter-day variabilities of paclitaxel were both less than 15%. This validated method for the assay of paclitaxel in micro-sample rat plasma made it feasible to study the pharmacokinetics of the drug in a single rat.
A sensitive high-performance liquid chromatographic (HPLC) method was developed for the determination of paclitaxel in micro-samples of rat plasma in order to study the mechanism of enhanced systemic exposure of paclitaxel co-administered with P-glycoprotein inhibitors. The assay involved solid-phase extraction procedures using 2′-methylpaclitaxel as the internal standard. Chromatographic separations were achieved using a ZORBAX ODS C18 column and mobile phase consisting of acetonitrile, methanol and ammonium acetate buffer (10 mM, pH 5.0) (48.5:16.5:35) pumped at 0.8 ml/min. The effluents were measured for UV absorption at 227 nm, with retention times of 8.5 and 11.0 min for paclitaxel and 2′-methylpaclitaxel, respectively. The chromatographic separation was excellent, with no endogenous interference. The standard curves showed a good linearity ( r=0.9994) over the concentration ranges of 10–1000 ng/ml. At 1000 ng/ml, the absolute recoveries of paclitaxel and 2′-methylpaclitaxel are 89 and 90%, respectively. The intra- and inter-day variabilities of paclitaxel were both less than 15%. This validated method for the assay of paclitaxel in micro-sample rat plasma made it feasible to study the pharmacokinetics of the drug in a single rat.
Author Wang, L.Z
Vaddi, H.K
Ho, P.C
Chan, Y.W
Yung, Chan Sui
Lee, H.S
Author_xml – sequence: 1
  givenname: L.Z
  surname: Wang
  fullname: Wang, L.Z
  organization: Department of Pharmacy, National University of Singapore, Science Drive 4, S117543, Singapore
– sequence: 2
  givenname: P.C
  surname: Ho
  fullname: Ho, P.C
  organization: Department of Pharmacology, National University of Singapore, Science Drive 4, S117543, Singapore
– sequence: 3
  givenname: H.S
  surname: Lee
  fullname: Lee, H.S
  organization: Department of Pharmacology, National University of Singapore, Science Drive 4, S117543, Singapore
– sequence: 4
  givenname: H.K
  surname: Vaddi
  fullname: Vaddi, H.K
  organization: Department of Pharmacy, National University of Singapore, Science Drive 4, S117543, Singapore
– sequence: 5
  givenname: Y.W
  surname: Chan
  fullname: Chan, Y.W
  organization: Department of Anaesthesiology, Singapore General Hospital, Outram Road, S169608, Singapore
– sequence: 6
  givenname: Chan Sui
  surname: Yung
  fullname: Yung, Chan Sui
  email: phacsy@nus.edu.sg
  organization: Department of Pharmacy, National University of Singapore, Science Drive 4, S117543, Singapore
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=14642409$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/12609667$$D View this record in MEDLINE/PubMed
BookMark eNqFkE1v1DAQQC1URLeFnwDyBQSHlLET28kJoRXQSisVBEicsGxnIowSJ3iyK_bfk-2u2iOn0WjefL0LdpbGhIw9F3AlQOi3X8GUojBQq9cg3wBoIYr6EVuJ2pSF1NWPM7a6R87ZBdFvAFCiqZ6wcyE1NFqbFfv5ZevSHGc3xzHxseOTC_2S_sWex8SHGPJYkBumHnl2M596R4Pjfs8dJ0wU57hbKrjDTNgW0y9HyK8_b9bcEbn9U_a4cz3hs1O8ZN8_fvi2vi42t59u1u83RSgbMRcKGx201zp44UuQoTN1C9iZQyiFqLsOwbfCeNe1lTIGQgit90bJslVNU16yV8e5Ux7_bJFmO0QK2Pcu4bgla0rQSkq1gOoILn8RZezslOPg8t4KsAex9k6sPVizIO2dWFsvfS9OC7Z-wPah62RyAV6eAEfB9V12KUR64CpdyQoOl747crjo2EXMlkLEFLCNGcNs2zH-55R_AzWXmQ
CODEN JPBADA
CitedBy_id crossref_primary_10_3390_pharmaceutics14051034
crossref_primary_10_1093_chromsci_bmr054
crossref_primary_10_7717_peerj_achem_3
crossref_primary_10_4155_bio_09_18
crossref_primary_10_1021_acsami_7b04066
crossref_primary_10_1093_chromsci_bmad070
crossref_primary_10_1016_j_ijpharm_2014_12_016
crossref_primary_10_1016_j_jchromb_2016_08_029
crossref_primary_10_1016_j_jpba_2005_02_023
crossref_primary_10_1016_j_msec_2011_04_011
crossref_primary_10_1080_10826070802039515
crossref_primary_10_3390_pharmaceutics14071401
crossref_primary_10_3109_10717544_2013_877100
crossref_primary_10_1016_j_jddst_2015_10_012
crossref_primary_10_1016_j_chroma_2004_12_025
crossref_primary_10_1007_s10337_016_3058_4
crossref_primary_10_1002_bmc_759
crossref_primary_10_1081_JLC_120030603
crossref_primary_10_1007_s13318_014_0203_z
crossref_primary_10_1080_10826070801924402
crossref_primary_10_1002_bmc_1706
crossref_primary_10_1007_s11095_014_1304_8
crossref_primary_10_1556_AChrom_28_2016_1_8
crossref_primary_10_4155_bio_14_48
crossref_primary_10_1007_s10337_010_1903_4
crossref_primary_10_1016_j_ajps_2013_07_026
crossref_primary_10_1002_bmc_3005
crossref_primary_10_4333_KPS_2004_34_2_125
Cites_doi 10.1016/0305-7372(93)90049-W
10.1016/0022-1759(93)90253-4
10.1016/0378-4347(94)00495-Q
10.1016/0378-4347(94)00456-F
10.1038/bjc.1993.488
10.1016/S0731-7085(99)00229-0
10.1016/0021-9673(96)00351-2
10.1177/10600280940280S501
10.3109/07357909509031919
10.1016/0378-4347(93)80100-I
10.1002/(SICI)1097-0231(19960731)10:10<1165::AID-RCM608>3.0.CO;2-J
10.1016/S0378-4347(98)00566-0
10.1016/S0378-4347(97)00502-1
10.1016/0378-4347(93)80341-Z
10.1016/0021-9673(94)87035-7
ContentType Journal Article
Copyright 2002 Elsevier Science B.V.
2003 INIST-CNRS
Copyright_xml – notice: 2002 Elsevier Science B.V.
– notice: 2003 INIST-CNRS
DBID IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.1016/S0731-7085(02)00611-8
DatabaseName Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1873-264X
EndPage 289
ExternalDocumentID 10_1016_S0731_7085_02_00611_8
12609667
14642409
S0731708502006118
Genre Journal Article
GroupedDBID ---
--K
--M
.~1
0R~
1B1
1RT
1~.
1~5
29L
4.4
457
4G.
53G
5GY
5VS
7-5
71M
8P~
9JM
9JN
AABNK
AACTN
AAEDT
AAEDW
AAIAV
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AARLI
AATCM
AAXUO
ABFNM
ABFRF
ABJNI
ABMAC
ABXDB
ABYKQ
ABZDS
ACDAQ
ACGFO
ACGFS
ACIUM
ACNNM
ACRLP
ADBBV
ADECG
ADEZE
ADMUD
AEBSH
AEFWE
AEKER
AENEX
AFKWA
AFTJW
AFXIZ
AFZHZ
AGHFR
AGUBO
AGYEJ
AHHHB
AIEXJ
AIKHN
AITUG
AJBFU
AJOXV
AJQLL
AJSZI
ALCLG
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
C45
CS3
DU5
EBS
EFJIC
EFLBG
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FLBIZ
FNPLU
FYGXN
G-2
G-Q
GBLVA
HMT
HMU
HVGLF
HZ~
IHE
J1W
KOM
M34
M36
M41
MO0
N9A
O-L
O9-
OAUVE
OGGZJ
OVD
OZT
P-8
P-9
P2P
PC.
Q38
R2-
RIG
RNS
ROL
RPZ
SCB
SCC
SCH
SDF
SDG
SDP
SES
SEW
SPC
SPCBC
SPT
SSK
SSP
SSZ
T5K
TEORI
WUQ
XFK
XPP
YK3
~G-
ABPIF
ABPTK
IQODW
AAXKI
AKRWK
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
AFJKZ
CITATION
7X8
ID FETCH-LOGICAL-c391t-5e96c6b66cb1b302cf78d0ef778d03118ffe0bd17bafd45770cccdbb7523d5993
IEDL.DBID .~1
ISSN 0731-7085
IngestDate Fri Oct 25 07:38:46 EDT 2024
Thu Sep 26 15:47:35 EDT 2024
Sat Sep 28 08:38:09 EDT 2024
Sun Oct 22 16:05:42 EDT 2023
Fri Feb 23 02:31:11 EST 2024
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords Reversed-phase HPLC
Paclitaxel
Rat plasma
Solid phase extraction
Biological fluid
Rat
Rodentia
HPLC chromatography
Blood plasma
Vertebrata
Reversed phase chromatography
Mammalia
Absorption
Ultraviolet detector
Analysis method
Revcrsed-phase HPLC
Animal
Taxane derivatives
Plant origin
Pharmacokinetics
Quantitative analysis
Language English
License CC BY 4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c391t-5e96c6b66cb1b302cf78d0ef778d03118ffe0bd17bafd45770cccdbb7523d5993
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 12609667
PQID 73065225
PQPubID 23479
PageCount 7
ParticipantIDs proquest_miscellaneous_73065225
crossref_primary_10_1016_S0731_7085_02_00611_8
pubmed_primary_12609667
pascalfrancis_primary_14642409
elsevier_sciencedirect_doi_10_1016_S0731_7085_02_00611_8
PublicationCentury 2000
PublicationDate 2003-02-26
PublicationDateYYYYMMDD 2003-02-26
PublicationDate_xml – month: 02
  year: 2003
  text: 2003-02-26
  day: 26
PublicationDecade 2000
PublicationPlace Amsterdam
PublicationPlace_xml – name: Amsterdam
– name: England
PublicationTitle Journal of pharmaceutical and biomedical analysis
PublicationTitleAlternate J Pharm Biomed Anal
PublicationYear 2003
Publisher Elsevier B.V
Elsevier Science
Publisher_xml – name: Elsevier B.V
– name: Elsevier Science
References J.G. Supko, R.V. Nair, M.V. Seiden, H. Lu, J. Pharm. Biomed. Anal. (1999) 1025–36.
Liebmann, Cook, Lipschultz (BIB4) 1993; 68
Sparreboom, van Tellingen, Nooijen, Beijnen (BIB6) 1995; 664
Poon, Wade, Bloomer, Clarke, Maltas (BIB13) 1996; 10
Grothaus, Raybould, Bignami, Lazo, Byrnes (BIB11) 1993; 158
Sparreboom, de Bruijn, Nooter, Loos, Stoter, Verweij (BIB8) 1998; 705
Donehower, Rowinsky (BIB2) 1993; 19
Song, Au (BIB7) 1995; 663
Bitsch, Ma, McDonald, Nieder, Shackleton (BIB12) 1993; 615
Koeller, Burris, Dorr (BIB3) 1994; 28
Hubert, Chiap, Moors, Bourguignon, Massart (BIB15) 1994; 665
Willey, Bekos, Gaver, Duncan (BIB5) 1993; 621
Huizing, Sewberath Misser, Peters (BIB1) 1995; 13
Guidance for industry-Bioanalytical Method Validation, Internet at
Leu, Chen, Schiff, Erlanger (BIB10) 1993; 53
Hempel, Lehmkuhl, Krumpelmann, Blaschke, Boos (BIB14) 1996; 745
The Merck Index, Eleventh edition, 1989.
Lee, Yoo, Lee (BIB18) 1999; 724
Donehower (10.1016/S0731-7085(02)00611-8_BIB2) 1993; 19
Huizing (10.1016/S0731-7085(02)00611-8_BIB1) 1995; 13
Grothaus (10.1016/S0731-7085(02)00611-8_BIB11) 1993; 158
Poon (10.1016/S0731-7085(02)00611-8_BIB13) 1996; 10
Willey (10.1016/S0731-7085(02)00611-8_BIB5) 1993; 621
Hempel (10.1016/S0731-7085(02)00611-8_BIB14) 1996; 745
10.1016/S0731-7085(02)00611-8_BIB9
Bitsch (10.1016/S0731-7085(02)00611-8_BIB12) 1993; 615
Hubert (10.1016/S0731-7085(02)00611-8_BIB15) 1994; 665
Sparreboom (10.1016/S0731-7085(02)00611-8_BIB6) 1995; 664
Lee (10.1016/S0731-7085(02)00611-8_BIB18) 1999; 724
Song (10.1016/S0731-7085(02)00611-8_BIB7) 1995; 663
Leu (10.1016/S0731-7085(02)00611-8_BIB10) 1993; 53
Sparreboom (10.1016/S0731-7085(02)00611-8_BIB8) 1998; 705
Koeller (10.1016/S0731-7085(02)00611-8_BIB3) 1994; 28
10.1016/S0731-7085(02)00611-8_BIB17
10.1016/S0731-7085(02)00611-8_BIB16
Liebmann (10.1016/S0731-7085(02)00611-8_BIB4) 1993; 68
References_xml – volume: 665
  start-page: 87
  year: 1994
  ident: BIB15
  publication-title: J. Chromatogr. A
  contributor:
    fullname: Massart
– volume: 724
  start-page: 357
  year: 1999
  end-page: 363
  ident: BIB18
  publication-title: J. Chromatogr. B
  contributor:
    fullname: Lee
– volume: 664
  start-page: 383
  year: 1995
  end-page: 391
  ident: BIB6
  publication-title: J. Chromatogr. B
  contributor:
    fullname: Beijnen
– volume: 745
  start-page: 173
  year: 1996
  end-page: 179
  ident: BIB14
  publication-title: J. Chromatogr.
  contributor:
    fullname: Boos
– volume: 663
  start-page: 337
  year: 1995
  end-page: 344
  ident: BIB7
  publication-title: J. Chromatogr. B
  contributor:
    fullname: Au
– volume: 158
  start-page: 5
  year: 1993
  end-page: 15
  ident: BIB11
  publication-title: J. Immunol. Methods
  contributor:
    fullname: Byrnes
– volume: 10
  start-page: 1165
  year: 1996
  end-page: 1168
  ident: BIB13
  publication-title: Rapid Commun. Mass. SP
  contributor:
    fullname: Maltas
– volume: 615
  start-page: 273
  year: 1993
  end-page: 280
  ident: BIB12
  publication-title: J. Chromatogr.
  contributor:
    fullname: Shackleton
– volume: 28
  start-page: S5
  year: 1994
  end-page: S36
  ident: BIB3
  publication-title: Ann. Pharmacother.
  contributor:
    fullname: Dorr
– volume: 53
  start-page: 1388
  year: 1993
  end-page: 1391
  ident: BIB10
  publication-title: Cancer Res.
  contributor:
    fullname: Erlanger
– volume: 19
  start-page: 63
  year: 1993
  end-page: 78
  ident: BIB2
  publication-title: Cancer Treat. Rev.
  contributor:
    fullname: Rowinsky
– volume: 13
  start-page: 381
  year: 1995
  end-page: 404
  ident: BIB1
  publication-title: Cancer Invest.
  contributor:
    fullname: Peters
– volume: 68
  start-page: 1104
  year: 1993
  end-page: 1109
  ident: BIB4
  publication-title: Br. J. Cancer
  contributor:
    fullname: Lipschultz
– volume: 621
  start-page: 231
  year: 1993
  end-page: 238
  ident: BIB5
  publication-title: J. Chromatogr. B
  contributor:
    fullname: Duncan
– volume: 705
  start-page: 159
  year: 1998
  end-page: 164
  ident: BIB8
  publication-title: J Chromatogr. B
  contributor:
    fullname: Verweij
– volume: 19
  start-page: 63
  year: 1993
  ident: 10.1016/S0731-7085(02)00611-8_BIB2
  publication-title: Cancer Treat. Rev.
  doi: 10.1016/0305-7372(93)90049-W
  contributor:
    fullname: Donehower
– volume: 158
  start-page: 5
  year: 1993
  ident: 10.1016/S0731-7085(02)00611-8_BIB11
  publication-title: J. Immunol. Methods
  doi: 10.1016/0022-1759(93)90253-4
  contributor:
    fullname: Grothaus
– volume: 664
  start-page: 383
  year: 1995
  ident: 10.1016/S0731-7085(02)00611-8_BIB6
  publication-title: J. Chromatogr. B
  doi: 10.1016/0378-4347(94)00495-Q
  contributor:
    fullname: Sparreboom
– ident: 10.1016/S0731-7085(02)00611-8_BIB17
– volume: 663
  start-page: 337
  year: 1995
  ident: 10.1016/S0731-7085(02)00611-8_BIB7
  publication-title: J. Chromatogr. B
  doi: 10.1016/0378-4347(94)00456-F
  contributor:
    fullname: Song
– volume: 68
  start-page: 1104
  year: 1993
  ident: 10.1016/S0731-7085(02)00611-8_BIB4
  publication-title: Br. J. Cancer
  doi: 10.1038/bjc.1993.488
  contributor:
    fullname: Liebmann
– ident: 10.1016/S0731-7085(02)00611-8_BIB9
  doi: 10.1016/S0731-7085(99)00229-0
– volume: 53
  start-page: 1388
  year: 1993
  ident: 10.1016/S0731-7085(02)00611-8_BIB10
  publication-title: Cancer Res.
  contributor:
    fullname: Leu
– volume: 745
  start-page: 173
  year: 1996
  ident: 10.1016/S0731-7085(02)00611-8_BIB14
  publication-title: J. Chromatogr.
  doi: 10.1016/0021-9673(96)00351-2
  contributor:
    fullname: Hempel
– volume: 28
  start-page: S5
  year: 1994
  ident: 10.1016/S0731-7085(02)00611-8_BIB3
  publication-title: Ann. Pharmacother.
  doi: 10.1177/10600280940280S501
  contributor:
    fullname: Koeller
– volume: 13
  start-page: 381
  year: 1995
  ident: 10.1016/S0731-7085(02)00611-8_BIB1
  publication-title: Cancer Invest.
  doi: 10.3109/07357909509031919
  contributor:
    fullname: Huizing
– volume: 621
  start-page: 231
  year: 1993
  ident: 10.1016/S0731-7085(02)00611-8_BIB5
  publication-title: J. Chromatogr. B
  doi: 10.1016/0378-4347(93)80100-I
  contributor:
    fullname: Willey
– volume: 10
  start-page: 1165
  year: 1996
  ident: 10.1016/S0731-7085(02)00611-8_BIB13
  publication-title: Rapid Commun. Mass. SP
  doi: 10.1002/(SICI)1097-0231(19960731)10:10<1165::AID-RCM608>3.0.CO;2-J
  contributor:
    fullname: Poon
– ident: 10.1016/S0731-7085(02)00611-8_BIB16
– volume: 724
  start-page: 357
  year: 1999
  ident: 10.1016/S0731-7085(02)00611-8_BIB18
  publication-title: J. Chromatogr. B
  doi: 10.1016/S0378-4347(98)00566-0
  contributor:
    fullname: Lee
– volume: 705
  start-page: 159
  year: 1998
  ident: 10.1016/S0731-7085(02)00611-8_BIB8
  publication-title: J Chromatogr. B
  doi: 10.1016/S0378-4347(97)00502-1
  contributor:
    fullname: Sparreboom
– volume: 615
  start-page: 273
  year: 1993
  ident: 10.1016/S0731-7085(02)00611-8_BIB12
  publication-title: J. Chromatogr.
  doi: 10.1016/0378-4347(93)80341-Z
  contributor:
    fullname: Bitsch
– volume: 665
  start-page: 87
  year: 1994
  ident: 10.1016/S0731-7085(02)00611-8_BIB15
  publication-title: J. Chromatogr. A
  doi: 10.1016/0021-9673(94)87035-7
  contributor:
    fullname: Hubert
SSID ssj0005194
Score 1.8831956
Snippet A sensitive high-performance liquid chromatographic (HPLC) method was developed for the determination of paclitaxel in micro-samples of rat plasma in order to...
SourceID proquest
crossref
pubmed
pascalfrancis
elsevier
SourceType Aggregation Database
Index Database
Publisher
StartPage 283
SubjectTerms Animals
Antineoplastic agents
Antineoplastic Agents, Phytogenic - blood
Antineoplastic Agents, Phytogenic - pharmacokinetics
Biological and medical sciences
Chromatography, High Pressure Liquid - methods
General aspects
Medical sciences
Paclitaxel
Paclitaxel - blood
Paclitaxel - pharmacokinetics
Pharmacology. Drug treatments
Rat plasma
Rats
Reproducibility of Results
Reversed-phase HPLC
Sensitivity and Specificity
Title Quantitation of paclitaxel in micro-sample rat plasma by a sensitive reversed-phase HPLC assay
URI https://dx.doi.org/10.1016/S0731-7085(02)00611-8
https://www.ncbi.nlm.nih.gov/pubmed/12609667
https://search.proquest.com/docview/73065225
Volume 31
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEB5CegmU0iZ9bNps51BCC1HWXj9kH8PSsEnbsKUJ5FQh2RJZSLwm3oXupb-9M7IXN4dQ6MkgJFnMJ42-secB8MHmzlniFaJMx1zCLKczFyWRsLEjfZnpPHQc4PztIp1exefXyfUWTDaxMOxW2en-Vqd7bd21jDppjur5fPSDNmcoOeMaW8XEkzmCPfGH8_j3X24eoS-GyJ0F9-6jeNoZfOPHYPzJTyKyx-6np7VuSGquLXfxOB_199Lpc3jWEUo8adf8ArZstQuHszYj9foIL_sAq-YID3HW56pe78HP7ytdLbs83bhwSCY0p-3-ZW9xXuEdu-uJRnMKYaS9gjWR7TuNZo0aG_Z9Z22JnAbqvrGlqG_oUsTp7OsEiZTr9Uu4Ov18OZmKruSCKKI8XIrE5mmRmjQtTGiiYFw4mZWBdZIfEQmZkA1MGUqjXRknUgZFUZTGSLJny4S4zivYrhaVfQNISEv-EBrFiY3JMMlCLvSjy5wIJY2LB3C8EbSq28waqnc5I2QUI6OCsfLIqGwA2QYO9WCLKNL-_xo6fABf_8KY7C8ycQfwfoOnovPFP010ZRerRpEGTImjJgN43cLcjyVTkIxFuf__63oLO945kEPk03ewvbxf2QMiOUsz9Lt4CE9Ozr5ML_4AvEz1VQ
link.rule.ids 315,783,787,4511,24130,27938,27939,45599,45693
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9tAEB7S5NBCKenbbZPMoYQWsrVkPVY6BtOgNI5xqQM5ddmVdqmhkUVkQ_3vOyPJiBxCICfBolmJ_WZnv5HmAfDZps5Z4hWiiEfcwiylPRdEgbChI3uZ6NR3nOB8OY2zq_DHdXS9A-NtLgyHVXa2v7XpjbXuRobdag6rxWL4i5TTl1xxjb1i4slPYI_YQErKvnd6fpFN-0gPv-mHyPcLFugTedpJmsEv3uhrM49I7juinle6poVzbceL-ylpczSd7cOLjlPiafvaL2HHlq_geNYWpd6c4LzPsapP8BhnfbnqzWv4_XOty1VXqhuXDsmL5srd_-xfXJR4wxF7otZcRRhJXbAivn2j0WxQY83h72wwkStB3da2ENUfOhcxm03GSLxcb97A1dn3-TgTXdcFkQepvxKRTeM8NnGcG98E3ih3Mik86yRfAlpnAtczhS-NdkUYSenleV4YI8mlLSKiO29ht1yW9j0ggS35W2gQRjYk3yTxudePLlLilCQXDuDbdqFV1RbXUH3UGSGjGBnljVSDjEoGkGzhUHe0RNEB8JDo4R34-geG5IKRlzuAoy2eirYY_zfRpV2ua0VGMCaaGg3gXQtzL0veIPmL8sPj3-sInmbzy4manE8vPsKzJlaQM-bjT7C7ul3bA-I8K3PY6fR_VNr4Eg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Quantitation+of+paclitaxel+in+micro-sample+rat+plasma+by+a+sensitive+reversed-phase+HPLC+assay&rft.jtitle=Journal+of+pharmaceutical+and+biomedical+analysis&rft.au=WANG%2C+L.+Z&rft.au=HO%2C+P.+C&rft.au=LEE%2C+H.+S&rft.au=VADDI%2C+H.+K&rft.date=2003-02-26&rft.pub=Elsevier+Science&rft.issn=0731-7085&rft.eissn=1873-264X&rft.volume=31&rft.issue=2&rft.spage=283&rft.epage=289&rft_id=info:doi/10.1016%2FS0731-7085%2802%2900611-8&rft.externalDBID=n%2Fa&rft.externalDocID=14642409
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0731-7085&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0731-7085&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0731-7085&client=summon